Shaping the Future: Hungarian Excellence in Research and Cancer Therapy

The program offers insight into Hungary’s evolving research ecosystem – from the national-level coordination of over 100 research groups to groundbreaking innovations in immune cell-based cancer therapies.

1. 1. Introduction of HUN-REN TKI
   The HUN-REN Centre for Research Management and Science Communication (TKI) supports more than 100 research groups spanning every scientific discipline — from humanities to life sciences and engineering. It serves as a virtual research institute with a mission to enable world-class research by providing strong administrative, legal, and innovation support. Thanks to its coordinated work, Hungarian researchers produce numerous high-impact publications and patents every year, contributing to Hungary’s global scientific reputation.
   Speaker: Frank Gábor, Innovation Manager (HUN-REN TKI)
   
   
2. 2. The Role of Genetically Modified Immune Cells in the Treatment of Solid Tumors: Presentation of the HUN-REN-DE Research Group’s Preclinical Studies on CAR T and CAR NK Cell-Based Therapies
   The presentation by the HUN-REN-DE Research Group will guide participants into an exciting and forward-looking area of medical science: the development of new therapies that reprogram the body’s own immune system to recognize and destroy cancer cells. These so-called CAR T and CAR NK cell therapies are already being used successfully in Hungary to treat certain blood cancers, and researchers are now working to adapt these methods to fight more challenging solid tumors as well.
   The presentation will also highlight real-world therapeutic applications already carried out at the University of Debrecen, offering a Hungarian example of how this technology can move beyond the laboratory and deliver results in actual patient care.
   In addition, the event will explore the role of the HUN-REN-DE Research Group in international immunotherapy research, and how it actively contributes to global collaborations at the forefront of science. Hungary is already an important player in the development of next-generation cancer treatments, and future international partnerships will bring us even closer to making these innovative therapies available to more people around the world.
   Speaker: Dr. Árpád Szöőr, Assistant Professor, Research Physician (University of Debrecen)